Corinne Johnson
Stock Analyst at Goldman Sachs
(2.96)
# 1,403
Out of 5,138 analysts
17
Total ratings
42.86%
Success rate
16.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corinne Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Maintains: Neutral | $37 → $39 | $30.57 | +27.58% | 1 | Jan 15, 2026 | |
| IMVT Immunovant | Maintains: Neutral | $18 → $28 | $26.27 | +6.59% | 2 | Dec 15, 2025 | |
| MBX MBX Biosciences | Initiates: Sell | $18 | $40.53 | -55.59% | 1 | Dec 4, 2025 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $10 → $20 | $14.30 | +39.86% | 2 | Sep 16, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $20 → $24 | $20.52 | +16.96% | 2 | Sep 5, 2025 | |
| RNA Avidity Biosciences | Reinstates: Buy | $55 | $72.51 | -24.15% | 2 | Jul 10, 2025 | |
| AVBP ArriVent BioPharma | Reinstates: Buy | $33 | $20.86 | +58.20% | 3 | Jul 10, 2025 | |
| NBIX Neurocrine Biosciences | Initiates: Buy | $182 | $132.39 | +37.47% | 1 | Jul 10, 2025 | |
| CGON CG Oncology | Upgrades: Buy | $43 → $50 | $54.73 | -8.64% | 3 | May 14, 2024 |
TG Therapeutics
Jan 15, 2026
Maintains: Neutral
Price Target: $37 → $39
Current: $30.57
Upside: +27.58%
Immunovant
Dec 15, 2025
Maintains: Neutral
Price Target: $18 → $28
Current: $26.27
Upside: +6.59%
MBX Biosciences
Dec 4, 2025
Initiates: Sell
Price Target: $18
Current: $40.53
Upside: -55.59%
Amylyx Pharmaceuticals
Sep 16, 2025
Maintains: Buy
Price Target: $10 → $20
Current: $14.30
Upside: +39.86%
Syndax Pharmaceuticals
Sep 5, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $20.52
Upside: +16.96%
Avidity Biosciences
Jul 10, 2025
Reinstates: Buy
Price Target: $55
Current: $72.51
Upside: -24.15%
ArriVent BioPharma
Jul 10, 2025
Reinstates: Buy
Price Target: $33
Current: $20.86
Upside: +58.20%
Neurocrine Biosciences
Jul 10, 2025
Initiates: Buy
Price Target: $182
Current: $132.39
Upside: +37.47%
CG Oncology
May 14, 2024
Upgrades: Buy
Price Target: $43 → $50
Current: $54.73
Upside: -8.64%